← Back to Search

CMR Imaging Techniques for Heart Disease (Myomapping Trial)

N/A

Recruiting

Led By Joseph U. Schoepf, MD

Research Sponsored by Medical University of South Carolina

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Subject must be previously diagnosed with or suspected to have one of the following conditions: Myocardial ischemia or infarction (group 1), Hypertrophic cardiomyopathy (group 2), Infiltrative cardiomyopathy (group 3), Myocarditis (group 4).

Subject must be 18-90 years of age.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Myomapping Trial Summary

This trial will test if a new MRI technique can help diagnose and treat patients with heart conditions.

Who is the study for?

This trial is for adults aged 18-90 with suspected or diagnosed heart conditions like ischemic heart disease, hypertrophic cardiomyopathy, infiltrative cardiomyopathy, or myocarditis. They must be referred for a CMR scan and can't participate if they have metal implants, acute psychiatric disorders, substance abuse issues, allergies to MRI contrast agents, are in an unstable condition or won't follow the study rules.Check my eligibility

What is being tested?

The trial is testing advanced Cardiac Magnetic Resonance Imaging (CMR) techniques to better diagnose and monitor various heart diseases. It aims to see how well these new fast quantitative imaging methods work compared to traditional ones.See study design

What are the potential side effects?

Since this trial involves imaging techniques rather than drugs, side effects may include discomfort during the procedure or reactions to contrast agents used in some MRIs such as mild allergic reactions.

Myomapping Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have or might have a heart condition such as blocked arteries, thickened heart muscle, a disease causing heart tissue buildup, or inflammation of the heart muscle.

Select...

I am between 18 and 90 years old.

Myomapping Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Clinical value of fast T1, T2, and T2* mapping of the left ventricle for the assessment of necrosis/scar, edema, and possible intramyocardial hemorrhage in patients with heart disease.

Myomapping Trial Design

1Treatment groups

Experimental Treatment

Group I: Additional 5 minute research MR scan of heart.Experimental Treatment1 Intervention

The purpose of this is to evaluate new, faster MR scans

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor

933 Previous Clinical Trials

7,394,395 Total Patients Enrolled

Joseph U. Schoepf, MDPrincipal InvestigatorMedical University of South Carolina

1 Previous Clinical Trials

149 Total Patients Enrolled

Media Library

Cardiac Magnetic Resonance (CMR) imaging techniques Clinical Trial Eligibility Overview. Trial Name: NCT02855554 — N/A

Cardiovascular Disease Research Study Groups: Additional 5 minute research MR scan of heart.

Cardiovascular Disease Clinical Trial 2023: Cardiac Magnetic Resonance (CMR) imaging techniques Highlights & Side Effects. Trial Name: NCT02855554 — N/A

Cardiac Magnetic Resonance (CMR) imaging techniques 2023 Treatment Timeline for Medical Study. Trial Name: NCT02855554 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the upper age limit of prospective participants in this study restricted to octogenarians?

"To be accepted into this trial, potential participants must fall between the age range of 18 and 90. On the other hand, 113 clinical trials are recruiting people younger than 18 while 843 target those beyond 65 years old."

Answered by AI

Is enrollment presently open for the experiment?

"According to the online resource, clinicaltrials.gov, this medical trial is in progress and has been since June 20th 2014. The page was last updated on November 29th 2022."

Answered by AI

Who should be the primary candidates for this experiment?

"This clinical trial admits 240 patients aged 18 to 90 with carditis. For admittance, participants must have one of the following: myocardial ischemia or infarction (group 1), hypertrophic cardiomyopathy (group 2), infiltrative cardiomyopathy (group 3) ,or myocarditis (group 4). Additionally, they must be previously diagnosed and referred for a clinically indicated CMR."

Answered by AI

How many individuals are actively engaged in this clinical experiment?

"Yes, the data hosted on clinicaltrials.gov affirms that this research project is presently seeking participants. It was initially published on June 20th 2014 and its last update occurred on November 29th 2022. The trial needs to enlist 240 patients from 1 centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Quantitative Cardiac Parametric Mapping

U. Joseph Schoepf, MD 2014. "Quantitative Cardiac Parametric Mapping". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02855554.

All > South Carolina > Heart Disease